Overview

DMB-I in the Treatment of Alzheimer Type Dementia

Status:
COMPLETED
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of DMB-I for the treatment of patients with Alzheimer type dementia.
Phase:
PHASE2
Details
Lead Sponsor:
Bigespas LTD
Treatments:
latrepirdine